Literature DB >> 26438678

Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.

Rhiannon Turney1, Jordan Peter Skittrall1, Joseph Donovan1, Daniel Agranoff1.   

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare condition with a mortality rate of up to 10%. Herein, we describe a case of DRESS syndrome secondary to allopurinol and which may have been precipitated by amoxicillin, the diagnostic challenge it represented and the successful treatment of the condition with corticosteroids. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26438678      PMCID： PMC4600823          DOI： 10.1136/bcr-2015-211222

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  40 in total

1.  High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome.

Authors:  Yukiko Kito; Taisuke Ito; Yoshiki Tokura; Hideo Hashizume
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

Review 2.  Management of nonimmediate hypersensitivity reactions to drugs.

Authors:  Jean-Claude Roujeau; Cynthia Haddad; Maren Paulmann; Maja Mockenhaupt
Journal:  Immunol Allergy Clin North Am       Date:  2014-08       Impact factor: 3.479

Review 3.  Drug-hypersensitivity syndrome: diagnosis and treatment.

Authors:  Rose L Hamm
Journal:  J Am Coll Clin Wound Spec       Date:  2012-06-23

4.  Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease.

Authors:  Y Kano; K Hiraharas; K Sakuma; T Shiohara
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

5.  Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation.

Authors:  Emilie Laban; Eva Hainaut-Wierzbicka; François Pourreau; Mokrane Yacoub; Emilie Sztermer; Gérard Guillet; Guy Touchard; Frank Bridoux
Journal:  Am J Kidney Dis       Date:  2010-01-27       Impact factor: 8.860

6.  Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome.

Authors:  V Descamps; F Bouscarat; S Laglenne; E Aslangul; B Veber; D Descamps; J L Saraux; M J Grange; M Grossin; E Navratil; B Crickx; S Belaich
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

Review 7.  Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system.

Authors:  Paulo R Criado; João Avancini; Claudia G Santi; Ana T Amoedo Medrado; Carlos E Rodrigues; Jozélio F de Carvalho
Journal:  Isr Med Assoc J       Date:  2012-09       Impact factor: 0.892

8.  Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.

Authors:  Rebecca J Brown; Kristina I Rother; Henry Artman; Mary Gail Mercurio; Roger Wang; R John Looney; Edward W Cowen
Journal:  Arch Dermatol       Date:  2009-01

9.  Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome.

Authors:  Dong-Hyun Kim; Young-Il Koh
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-06       Impact factor: 5.764

10.  Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?

Authors:  Sophie Bouvresse; Laurence Valeyrie-Allanore; Nicolas Ortonne; Marie Pauline Konstantinou; Sylvia H Kardaun; Martine Bagot; Pierre Wolkenstein; Jean-Claude Roujeau
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123
View more
  1 in total

1.  Successful treatment of drug reaction with eosinophilia and systemic symptoms syndrome relapse with oral pulsed dexamethasone.

Authors:  Claire-Audrey Y Bayan; Adriana Lopez; Natalia M Fontecilla; Larisa J Geskin
Journal:  JAAD Case Rep       Date:  2018-10-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.